𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modeling Imatinib-Treated Chronic Myelogenous Leukemia: Reducing the Complexity of Agent-Based Models

✍ Scribed by Peter S. Kim; Peter P. Lee; Doron Levy

Book ID
107385948
Publisher
Springer
Year
2007
Tongue
English
Weight
708 KB
Volume
70
Category
Article
ISSN
1522-9602

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Analysis of the impact of imatinib mesyl
Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome–positive chronic myelogenous leukemia treated with interferon-Ξ± regimens for early chronic phase
✍ Hagop Kantarjian; Susan O'Brien; Jorges Cortes; Jianqin Shan; Francis Giles; Gui πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The effect on prognosis of adding imatinib mesylate to the treatment of patients with Philadelphia chromosome (Ph)‐positive chronic myelogenous leukemia (CML) has not been explored fully. The objective of the current study was to evaluate the benefit of adding imatinib to